Providence First Trust Co Purchases Shares of 1,614 HCA Healthcare, Inc. $HCA

Providence First Trust Co acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,614 shares of the company’s stock, valued at approximately $754,000.

Several other large investors have also added to or reduced their stakes in HCA. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare in the third quarter worth about $26,000. Holos Integrated Wealth LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $31,000. Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $34,000. Finally, Key Capital Management INC purchased a new position in HCA Healthcare in the fourth quarter valued at $35,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $428.94 on Wednesday. The company’s 50 day simple moving average is $495.58 and its two-hundred day simple moving average is $486.47. The firm has a market capitalization of $95.16 billion, a price-to-earnings ratio of 14.75, a price-to-earnings-growth ratio of 1.36 and a beta of 1.18. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the prior year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research analyst reports. Sanford C. Bernstein dropped their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a report on Tuesday, April 28th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. TD Cowen dropped their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, April 27th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Finally, Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $517.82.

Insider Transactions at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 13,714 shares of company stock worth $7,050,460. 1.50% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.